Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02849444
What this trial is testing

Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance

Who this might be right for
Multiple Myeloma
Celgene 326
Testing effectiveness (Phase 2)Temporarily pausedNCT05199311
What this trial is testing

Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 66
Testing effectiveness (Phase 2)Looking for participantsNCT04634552
What this trial is testing

Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematological Malignancies
Janssen Research & Development, LLC 510
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT05064358
What this trial is testing

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 177
Large-scale testing (Phase 3)Study completedNCT00719563
What this trial is testing

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+7 more
Alliance for Clinical Trials in Oncology 364
Testing effectiveness (Phase 2)Active Not RecruitingNCT05497804
What this trial is testing

Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

Who this might be right for
ISS Stage III Plasma Cell MyelomaMultiple Myeloma
Mayo Clinic 17
Large-scale testing (Phase 3)UnknownNCT00872352
What this trial is testing

Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients

Who this might be right for
Multiple MyelomaPeripheral Neuropathy
Wolfson Medical Center 30
Early research (Phase 1)Ended earlyNCT00909948
What this trial is testing

Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant

Who this might be right for
Non Hodgkin's LymphomaHodgkin DiseaseMultiple Myeloma
Massachusetts General Hospital 7
Not applicableActive Not RecruitingNCT04221178
What this trial is testing

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

Who this might be right for
Plasma Cell Myeloma
Memorial Sloan Kettering Cancer Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05438043
What this trial is testing

Daratumumab

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 213
Testing effectiveness (Phase 2)Study completedNCT01729091
What this trial is testing

Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasma Cell Myeloma
M.D. Anderson Cancer Center 72
Very early researchNot Yet RecruitingNCT07322159
What this trial is testing

IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04052880
What this trial is testing

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Larysa Sanchez 17
Early research (Phase 1)Study completedNCT02561962
What this trial is testing

Study in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 42
Testing effectiveness (Phase 2)Study completedNCT00008268
What this trial is testing

Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT07206810
What this trial is testing

The Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Myeloma
The First Affiliated Hospital of Soochow University 419
Testing effectiveness (Phase 2)WithdrawnNCT00995059
What this trial is testing

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic
Early research (Phase 1)UnknownNCT05266768
What this trial is testing

Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y002#

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Chunrui Li 36
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Next Page